Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New ovine enzootic abortion vaccine in development
"We are very encouraged by the new vaccine results." - Dr David Longbottom.
The work is led by Dr David Longbottom, of the Moredun Research Institute. 

Scientists at the Moredun Research Institute are developing a new vaccine against ovine enzootic abortion.

Ovine enzootic abortion is the most common cause of abortion in sheep in the UK, and is caused by the bacteria Chlamydia abortus, which invades the placenta during pregnancy. The disease can also cause life-threatening illness and abortion in humans.

The disease spreads through ingestion and inhalation, and a high level of environmental contamination by infected ewes in lambing pens is a key point in the spread of disease.

Led by Dr David Longbottom, the scientists at Moredun have completed the first stage in the development of the vaccine, which is similar to the live variation, but does not possess the ability to grow and cause infections in the host animal. 

Dr Longbottom commented on the ongoing development process: “We are very encouraged that the new vaccine results in a similar protective response to that generated following a natural infection or resulting from the live vaccines but importantly without the ability to cause disease.”

More about the vaccine can be read in this study, published in Vaccines

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.